m.adebayo

TL2 Moderator · Oulu

Contributes reviews on supplier material. Based in Oulu.

Joined 24 January 2025 · last posted 2d

80 posts, newest first. Showing up to 150.

Submitting a sample: the process end to end Replied, post #112 · Sourcing › Independent verification · 26 Jul 2026 · 21 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Transit times by route, from a logged dataset Replied, post #17 · Sourcing › Logistics · 18 Jul 2026 · 16 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #31 · Practice › Interactions · 16 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
Common supplements people ask about, assessed one at a time Replied, post #43 · Practice › Interactions · 13 Jul 2026 · 0 likes Coming back to post #41, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
Follow-up: How compounding permissions changed when supply normalised Replied, post #17 · Sourcing › Regulatory · 13 Jul 2026 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #61 · Analytics › Impurities & related substances · 9 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #121 · Practice › Storage & stability · 10 Jun 2026 · 0 likes I read post #119 twice before replying, because I had assumed the opposite. Published stability data applies specifically to the formulation studied, under the specific…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #76 · Practice › Storage & stability · 3 Jun 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #68 · Practice › Administration · 2 Jun 2026 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Cold solution and stinging: warming the vial in your hands for a minute before…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #11 · Compounds › Secretagogues & GH axis · 24 May 2026 · 8 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #24 · Evidence › Journal club · 21 May 2026 · 11 likes I read post #22 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
Reading a trial's population section before its results Replied, post #37 · Evidence › Trials · 20 May 2026 · 1 like Worth separating two things that post #33 runs together. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
An appeal that succeeded, with the letter structure Replied, post #4 · Access › Insurance & coverage · 18 May 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Started this topic · Pharmacology › Receptor biology · 18 May 2026 · 3 likes Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. A documentation question…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #49 · Practice › Reconstitution · 17 May 2026 · 5 likes Coming back to post #47, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
CJC-1295 with and without DAC: what the modification does Replied, post #50 · Compounds › Secretagogues & GH axis · 6 May 2026 · 7 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #13 · Compounds › Oral incretins · 30 Apr 2026 · 1 like Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #15 · Analytics › COA interpretation · 30 Apr 2026 · 14 likes post #14 answers the question as asked. The question underneath it is different. When a document puts the specification in the result column, it has told you the…
List price versus negotiated price versus what you pay Replied, post #101 · Access › Pricing · 16 Apr 2026 · 0 likes Coming back to post #99, because the follow-up matters more than the original answer. Biosimilars and future generics: as patents expire, biosimilar and generic…
About the Doc review category Replied, post #5 · Documentation › Doc review · 3 Apr 2026 · 5 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #127 · Access › Pricing · 26 Mar 2026 · 6 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #68 · Compounds › Repair & healing peptides · 15 Mar 2026 · 0 likes post #67 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Forced degradation studies: designing one that is informative Replied, post #18 · Analytics › Method validation · 11 Mar 2026 · 6 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Oral semaglutide bioavailability and its variability between people Replied, post #40 · Compounds › Oral incretins · 8 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
The lowest dose that does anything: is that a real question? Replied, post #70 · Practice › Dosing & titration · 6 Mar 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Contributing data without breaching anyone's privacy Replied, post #54 · Data & Tools › Datasets · 5 Mar 2026 · 4 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
Follow-up: Reconciling a label claim with a content assay Replied, post #7 · Analytics › COA interpretation · 22 Feb 2026 · 2 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #31 · Research Methods › N-of-1 designs · 12 Feb 2026 · 22 likes On post #27 — agreed on the reasoning, with one qualification. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores)…
Reading SURMOUNT-1 without the press release — one year on Replied, post #44 · Compounds › Tirzepatide · 3 Feb 2026 · 3 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #20 · Analytics › Mass spectrometry · 28 Jan 2026 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Second pass at: Submitting a sample: the process end to end Replied, post #3 · Sourcing › Independent verification · 15 Jan 2026 · 31 likes Coming back to the opening post, because the follow-up matters more than the original answer. Janoshik Analytical: chromatographic purity and mass-spectrometric…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #38 · Analytics › Method validation · 5 Jan 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Aggregates and why a purity assay may miss them entirely Replied, post #43 · Analytics › Impurities & related substances · 1 Jan 2026 · 33 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
Filter needles: when they help and what they cost you Replied, post #10 · Devices › Syringes & needles · 23 Dec 2025 · 9 likes Coming back to post #8, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Amylin receptor signalling and satiety — what changed since Replied, post #7 · Pharmacology › Receptor biology · 22 Dec 2025 · 0 likes post #6 is right about the mechanism and I think understates the practical bit. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #5 · Pharmacology › Receptor biology · 7 Dec 2025 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a…
Waist circumference technique and its repeatability Replied, post #24 · Outcomes › Progress reports · 7 Dec 2025 · 19 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #117 · Lounge › Off topic · 23 Oct 2025 · 7 likes post #116 answers the question as asked. The question underneath it is different. Politics and public policy: healthcare policy that affects access to these compounds…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #114 · Start Here › Welcome · 23 Oct 2025 · 15 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
What pooling buys you and what it destroys Replied, post #34 · Evidence › Meta-analyses · 3 Oct 2025 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Guidelines revision: what changed and why — one year on Replied, post #21 · Meta › Announcements · 2 Oct 2025 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 9 likes On the opening post — agreed on the reasoning, with one qualification. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection.…
EU-wide position versus national implementation — what changed since Replied, post #2 · Regional › European Union · 7 Sep 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Netherlands: CBG-MEB implements framework. GPs are first point of contact.…
Follow-up: Why appetite effects are mostly central Replied, post #33 · Pharmacology › Receptor biology · 5 Sep 2025 · 0 likes Worth separating two things that post #29 runs together. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite)…
Documentation that appears only after payment Replied, post #15 · Sourcing › Red flags · 31 Aug 2025 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #51 · Practice › Dosing & titration · 21 Aug 2025 · 0 likes Worth separating two things that post #47 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #55 · Sourcing › Regulatory · 20 Jul 2025 · 28 likes Worth separating two things that post #51 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #82 · Evidence › Trials · 20 Jul 2025 · 5 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #65 · Compounds › Oral incretins · 16 Jul 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #2 · Sourcing › Red flags · 16 Jul 2025 · 14 likes Picking up the opening post: that is the part I would want checked first. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #15 · Compounds › Oral incretins · 6 Jul 2025 · 1 like This follows post #12 rather than contradicting it. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety…
Needle changes between doses on a reusable pen Replied, post #18 · Devices › Pens & autoinjectors · 2 Jul 2025 · 2 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
Coming back to: What published stability data actually covers, and what it does not Replied, post #66 · Practice › Storage & stability · 18 Jun 2025 · 12 likes This follows post #63 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #102 · Compounds › Tirzepatide · 5 Jun 2025 · 9 likes I read post #100 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
Pre-registering a personal experiment, seriously Replied, post #40 · Research Methods › N-of-1 designs · 29 May 2025 · 9 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
DXA precision and the least significant change for lean mass — the long version Replied, post #80 · Outcomes › Body composition · 22 May 2025 · 0 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
A well-designed study with a badly written abstract Replied, post #86 · Evidence › Study critique · 16 May 2025 · 15 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #15 · Compounds › Repair & healing peptides · 16 May 2025 · 6 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
Validating a calculator against hand arithmetic — what changed since Replied, post #44 · Data & Tools › Calculators · 1 May 2025 · 0 likes Coming back to post #42, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Units, standards, and other things that quietly hold the world together Replied, post #32 · Lounge › Off topic · 30 Apr 2025 · 2 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
Carryover and the ghost peak from last week's standard Replied, post #41 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Telehealth prescribing models in the US Replied, post #70 · Regional › North America · 14 Mar 2025 · 0 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
Follow-up: Open-label extensions: what survives and what does not Replied, post #5 · Evidence › Trials · 3 Mar 2025 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #18 · Compounds › Semaglutide · 21 Feb 2025 · 2 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Review: a draft on reconstitution arithmetic, with objections Replied, post #30 · Documentation › Doc review · 21 Feb 2025 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
Reading a supplementary appendix and finding the interesting part Replied, post #85 · Evidence › Trials · 5 Feb 2025 · 0 likes Worth separating two things that post #81 runs together. Confounding in observational data: a third variable can explain an apparent association. In a randomised trial,…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #45 · Evidence › Meta-analyses · 3 Feb 2025 · 0 likes Picking up post #42: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #9 · Evidence › Meta-analyses · 26 Jan 2025 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
Fixed versus detachable needles: the trade-offs Replied, post #110 · Devices › Syringes & needles · 13 Jan 2025 · 6 likes post #109 is right about the mechanism and I think understates the practical bit. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual…
Recovery when intake is low: what to cut first Replied, post #32 · Nutrition & Training › Resistance training · 11 Jan 2025 · 4 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
Body image changing more slowly than the body Replied, post #135 · Wellbeing › Mental health · 25 Dec 2024 · 26 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #69 · Evidence › Journal club · 23 Dec 2024 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Time to steady state after a dose increase Replied, post #79 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. Renal clearance: these compounds are cleared partly via the kidney. In severe…
Revisiting: Moderation log format change Replied, post #11 · Meta › Announcements · 30 Oct 2024 · 3 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #60 · Analytics › Method validation · 27 Oct 2024 · 2 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #68 · Clinical › Bloodwork · 30 Sep 2024 · 0 likes post #67 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #2 · Compounds › Oral incretins · 18 Sep 2024 · 7 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #12 · Compounds › Retatrutide · 31 Aug 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Circumference measurements as a poor man's composition estimate Replied, post #85 · Outcomes › Body composition · 21 Aug 2024 · 2 likes post #84 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Assessing a warm arrival: the decision process — one year on Replied, post #117 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Worth separating two things that post #113 runs together. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal…